Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2006 1
2014 1
2018 1
2020 1
2021 1
2022 1
2023 1
2024 2
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for amniotic membrane four neurotrophic keratopathy
Your search for Amniotic Membrane for Neurotophic Keratopathy retrieved no results
Clinical Outcomes of In-office Sutureless Amniotic Membrane Transplantation in Persistent Epithelial Defect.
Choi CM, Jeon HS. Choi CM, et al. Korean J Ophthalmol. 2022 Apr;36(2):87-96. doi: 10.3341/kjo.2021.0095. Epub 2021 Nov 26. Korean J Ophthalmol. 2022. PMID: 34823345 Free PMC article.
PURPOSE: To investigate the efficacy of outpatient clinic-based sutureless amniotic membrane transplantation (AMT) along with therapeutic contact lens (T-lens) application in eyes with persistent epithelial defects (PED). ...RESULTS: Among nine eyes with PED, three …
PURPOSE: To investigate the efficacy of outpatient clinic-based sutureless amniotic membrane transplantation (AMT) along with …
Outcomes and success of amniotic membrane transplantation for the treatment of corneal diseases.
Dikmetas O, Kapucu Y, Cankaya AB, Kocabeyoglu S. Dikmetas O, et al. Cutan Ocul Toxicol. 2024 Mar;43(1):33-37. doi: 10.1080/15569527.2023.2275018. Epub 2023 Oct 31. Cutan Ocul Toxicol. 2024. PMID: 37879107
PURPOSE: The amniotic membrane (AM), the inner layer of the placenta, is a semitransparent, avascular, and thin tissue that is useful due to its structure. Amniotic membrane transplantation (AMT) avoids the need for keratoplasty to prevent corneal perf …
PURPOSE: The amniotic membrane (AM), the inner layer of the placenta, is a semitransparent, avascular, and thin tissue that is …
Medical and surgical interventions for neurotrophic keratopathy.
Kruoch Z, Choo AY, Kemp A, Gonzales M, Yim TW, McCann P, Liu SH, Ting DSJ, Kuo IC. Kruoch Z, et al. Cochrane Database Syst Rev. 2025 Dec 5;12(12):CD015723. doi: 10.1002/14651858.CD015723.pub2. Cochrane Database Syst Rev. 2025. PMID: 41347649
RATIONALE: Alterations to the corneal nerves can lead to neurotrophic keratopathy (NK), which is marked by breakdown of the corneal epithelium and impaired healing. ...Only one trial evaluated surgical interventions, comparing amniotic membrane transpl …
RATIONALE: Alterations to the corneal nerves can lead to neurotrophic keratopathy (NK), which is marked by breakdown of the co …
Topical insulin in neurotrophic keratopathy after diabetic vitrectomy.
Eleiwa TK, Khater AA, Elhusseiny AM. Eleiwa TK, et al. Sci Rep. 2024 May 14;14(1):10986. doi: 10.1038/s41598-024-60699-y. Sci Rep. 2024. PMID: 38744994 Free PMC article.
To assess the efficacy and safety of topical insulin (TI) for treating neurotrophic keratopathy (NK) within one-month post-diabetic vitrectomy (DV) compared to conventional non-invasive measures, we conducted this retrospective case-control study including all eyes …
To assess the efficacy and safety of topical insulin (TI) for treating neurotrophic keratopathy (NK) within one-month post-dia …
Topical insulin as a novel treatment for persistent epithelial defects and other ocular surface disorders: a systematic review.
Bievel Radulescu R, Ferrari S, Stanca HT, Ponzin D. Bievel Radulescu R, et al. Graefes Arch Clin Exp Ophthalmol. 2025 Sep;263(9):2427-2445. doi: 10.1007/s00417-025-06840-7. Epub 2025 May 17. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40381039
CONCLUSIONS: Our systematic review demonstrates that topical insulin is a promising therapeutic option for persistent epithelial defects, diabetic keratopathy following vitrectomy, neurotrophic keratopathy, and dry eye syndrome, significantly enhancing cornea …
CONCLUSIONS: Our systematic review demonstrates that topical insulin is a promising therapeutic option for persistent epithelial defects, di …
Shelf-Stable, Cryopreserved Amniotic Membrane for the Management of Ocular Surface Disease: A Retrospective Assessment.
Cushman S. Cushman S. Clin Optom (Auckl). 2025 Dec 21;17:409-415. doi: 10.2147/OPTO.S563708. eCollection 2025. Clin Optom (Auckl). 2025. PMID: 41459351 Free PMC article.
PURPOSE: To assess both the short- and long-term clinical outcomes following adjunctive treatment with shelf-stable, cryopreserved amniotic membrane (CAM) in patients with ocular surface disease (OSD). METHODS: This was a single-center, retrospective study of consec …
PURPOSE: To assess both the short- and long-term clinical outcomes following adjunctive treatment with shelf-stable, cryopreserved amniot …
Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers.
Solomon A, Meller D, Prabhasawat P, John T, Espana EM, Steuhl KP, Tseng SC. Solomon A, et al. Ophthalmology. 2002 Apr;109(4):694-703. doi: 10.1016/s0161-6420(01)01032-6. Ophthalmology. 2002. PMID: 11927426
PURPOSE: To describe the clinical outcome of amniotic membrane transplantation (AMT) for nontraumatic corneal perforations, descemetoceles, and deep ulcers. ...INTERVENTION: Three or four layers of amniotic membrane (AM) were applied over the ul …
PURPOSE: To describe the clinical outcome of amniotic membrane transplantation (AMT) for nontraumatic corneal perforations, de …
Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.
Prabhasawat P, Tesavibul N, Komolsuradej W. Prabhasawat P, et al. Br J Ophthalmol. 2001 Dec;85(12):1455-63. doi: 10.1136/bjo.85.12.1455. Br J Ophthalmol. 2001. PMID: 11734521 Free PMC article. Clinical Trial.
AIMS: To evaluate the efficacy of amniotic membrane transplantation (AMT) in persistent corneal epithelial defect with or without stromal thinning and corneal perforation. ...The causes of persistent epithelial defect were neurotrophic keratopathy (24 …
AIMS: To evaluate the efficacy of amniotic membrane transplantation (AMT) in persistent corneal epithelial defect with or with …
Application of the amniotic membrane in ocular surface pathology.
Gris O, Güell JL, Lopez-Navidad A, Caballero F, Del Campo Z. Gris O, et al. Ann Transplant. 1999;4(3-4):82-4. Ann Transplant. 1999. PMID: 10853789
The follow-up period varied between 2 and 6.5 months (mean = 4 months). Amniotic membrane was obtained by elective Caesarean, and it was preserved at -80 degrees C. ...In conclusion, the implantation of preserved human amniotic membrane can favour the …
The follow-up period varied between 2 and 6.5 months (mean = 4 months). Amniotic membrane was obtained by elective Caesarean, …
Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer.
Wróbel-Dudzińska D, Alio J, Rodriguez A, Suchodoła-Ratajewicz E, Kosior-Jarecka E, Rymgayłło-Jankowska B, Ćwiklińska-Haszcz A, Żarnowski T. Wróbel-Dudzińska D, et al. J Ophthalmol. 2018 Jun 20;2018:3538764. doi: 10.1155/2018/3538764. eCollection 2018. J Ophthalmol. 2018. PMID: 30026985 Free PMC article.
In one of the patients, an amniotic membrane was transplanted due to the lack of improvement of his local condition. ...CONCLUSIONS: Autologous platelet-rich plasma is a blood-based product which seems efficient in the treatment of neurotrophic keratopathy …
In one of the patients, an amniotic membrane was transplanted due to the lack of improvement of his local condition. ...CONCLU …
13 results